Lifecare ASA Operational restructuring to support transition to production and centralization of operations

26 Mar 2026 15:02 CET

Bergen, Norway, 26 March 2026 -- Lifecare ASA (LIFE) has reached key
development milestones and is transitioning from technology development
towards product realisation and production, representing a strategic
de-risking of the Company's path to commercialisation.

As part of this development, the Board of Directors has resolved to centralise
the Group's operations, with manufacturing activities to be established in
Bergen, Norway, and chemistry-related activities to be consolidated within the
Company's UK subsidiary in Bristol, United Kingdom.

As a consequence of this strategic realignment, the Board has resolved to
initiate the discontinuation of the business operations of its wholly owned
subsidiary, Lifecare Germany GmbH, as part of an optimisation and streamlining
of the Group's operational structure.

The decision follows a thorough evaluation of the Company's operations and
reflects a transition towards a more focused, centralised and efficient
organisation, with relevant activities being transferred from Germany to the
UK and Norway.

Strategic rationale
The discontinuation of the German operations is expected to:

* Optimise and streamline the Group's operational structure
* Improve efficiency and reduce complexity through centralisation of
activities
* Enable faster execution and shorter timelines in the transition to
production
* Support the Company's strategic shift from R&D towards production and
commercialisation
* Deliver a significant reduction in the Group's operating cost base,
primarily through reduced personnel and facility-related expenses

As part of this process, the Company will centralise its manufacturing
activities in Bergen, Norway, where production capabilities will be
established and integrated with the Group's core organisation. This is
expected to provide improved operational control, shorter development and
production timelines, and increased organisational efficiency.

Implementation
The discontinuation of the German operations will be carried out as a formal
liquidation process, representing a structured and solvent wind-down of the
subsidiary, in compliance with applicable German legal requirements.

The Company has engaged external legal advisors to support the process.

The implementation is expected to take place over the coming months. The
formal liquidation process in Germany includes a statutory creditor period of
12months.

Financial impact
The operational restructuring is expected to result in a materially reduction
in the Group's cost. At the same time, certain one-off costs related to the
discontinuation, including employee-related costs and settlement of
contractual obligations, are expected.

The Company will continue to monitor the liquidity position of Lifecare
Germany GmbH during the process and will take appropriate actions if required.

Outlook
The measures are expected to accelerate the Company's transition to scalable
production and commercialisation.

The Company will provide further updates as the process progresses.

About us
Lifecare ASA is a medical sensor company developing technology for sensing and
monitoring of various body analytes. Lifecare's focus is to bring the next
generation of Continuous Glucose Monitoring systems to market. Lifecare
enables osmotic pressure as sensing principle. Lifecare's sensor technology is
suitable for identifying and monitoring the occurrence of a wide range of
analytes and molecules in the human body and in pets.

Contacts
For further information, please contact:

Joacim Holter, CEO, joacim.holter@lifecare.no, +47 40 05 90 40

This information has been submitted pursuant to the Securities Trading Act §
5-12 and MAR. The information was submitted for publication, through the
agency of the contact persons set out above, at 2026-03-26 15:02 CET.

More information:
Access the news on Oslo Bors NewsWeb site

669474_Lifecare ASA Operational restructuring to support transition to production and centralization of operations.pdf